Literature DB >> 18458956

Flow-mediated vasodilatation of the brachial artery in children with chronic kidney disease.

Amy C Wilson1, Elaine Urbina, Sandra A Witt, Betty J Glascock, Thomas R Kimball, Mark Mitsnefes.   

Abstract

We sought to determine flow-mediated vasodilatation (FMD) of the brachial artery and to assess the relationship of FMD with multiple demographic, clinical and biochemical parameters and cardiac and vascular structure and function in children with chronic kidney disease (CKD) stages 2-4. Forty-three patients, aged 6-20 years, with CKD [mean glomerular filtration rate (GFR) 47 +/- 21 ml/min per 1.73 m2 body surface area, range 16-89 ml/min per 1.73 m2] and 34 healthy age-matched controls were included and studied cross-sectionally between 2001 and 2005. The peak FMD was similar in the CKD and control subjects (mean 6.3% vs 6.7%, P = 0.85). However, abnormally low FMD (< 1.1%) was found in ten (23%) children with CKD. Among children with CKD, those with low FMD were younger, shorter, lighter, and had lower body mass index (BMI) than children with normal FMD, but the difference reached statistical significance only for weight and BMI. Serum triglyceride levels were significantly lower in those with low FMD; otherwise, the two groups were similar with respect to multiple clinical and biochemical parameters. Cardiac and vascular structure was similar in children with normal and low FMD. In conclusion, children with CKD stage 2-4 appear to have increased prevalence of decreased FMD of the brachial artery. However, our study identified few significant factors associated with low FMD in children with CKD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458956     DOI: 10.1007/s00467-008-0815-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  24 in total

1.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.

Authors:  Mary C Corretti; Todd J Anderson; Emelia J Benjamin; David Celermajer; Francois Charbonneau; Mark A Creager; John Deanfield; Helmut Drexler; Marie Gerhard-Herman; David Herrington; Patrick Vallance; Joseph Vita; Robert Vogel
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

2.  Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients.

Authors:  C van Guldener; J Lambert; M J Janssen; A J Donker; C D Stehouwer
Journal:  Nephrol Dial Transplant       Date:  1997       Impact factor: 5.992

3.  Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism.

Authors:  Mark M Mitsnefes; Thomas R Kimball; Janis Kartal; Sandra A Witt; Betty J Glascock; Philip R Khoury; Stephen R Daniels
Journal:  J Am Soc Nephrol       Date:  2005-07-27       Impact factor: 10.121

4.  Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease.

Authors:  B Pannier; A P Guerin; S J Marchais; F Metivier; M E Safar; G M London
Journal:  Kidney Int       Date:  2000-03       Impact factor: 10.612

5.  Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease.

Authors:  P Clarkson; D S Celermajer; A J Powe; A E Donald; R M Henry; J E Deanfield
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

6.  Vascular function in children after renal transplantation.

Authors:  Marc R Lilien; Erik S Stroes; Jos Op't Roodt; Saskia de Jongh; Cornelis H Schröder; Hein A Koomans
Journal:  Am J Kidney Dis       Date:  2003-03       Impact factor: 8.860

7.  Hemodialysis acutely impairs endothelial function in children.

Authors:  Marc R Lilien; Hein A Koomans; Cornelis H Schröder
Journal:  Pediatr Nephrol       Date:  2004-12-31       Impact factor: 3.714

8.  Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors.

Authors:  Andreas Alexander Meyer; Günther Kundt; Michael Steiner; Peter Schuff-Werner; Wolfgang Kienast
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

9.  Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension.

Authors:  J A Panza; A A Quyyumi; J E Brush; S E Epstein
Journal:  N Engl J Med       Date:  1990-07-05       Impact factor: 91.245

10.  Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients.

Authors:  Kayser Caglar; Mahmut Ilker Yilmaz; Mutlu Saglam; Erdinc Cakir; Cengizhan Acikel; Tayfun Eyileten; Mujdat Yenicesu; Yusuf Oguz; Abdulgaffar Vural; Juan Jesus Carrero; Jonas Axelsson; Bengt Lindholm; Peter Stenvinkel
Journal:  Clin J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 8.237

View more
  7 in total

1.  Brachial artery flow-mediated dilatation and carotid intima medial thickness in pediatric nephrotic syndrome: a cross-sectional case-control study.

Authors:  Illaparambath Rahul; Sriram Krishnamurthy; Santhosh Satheesh; Niranjan Biswal; Zachariah Bobby; Subitha Lakshminarayanan
Journal:  Clin Exp Nephrol       Date:  2014-03-18       Impact factor: 2.801

2.  Effect of cholecalciferol on local arterial stiffness and endothelial dysfunction in children with chronic kidney disease.

Authors:  Mehmet Baha Aytaç; Murat Deveci; Kenan Bek; Özlem Kayabey; Zelal Ekinci
Journal:  Pediatr Nephrol       Date:  2015-10-02       Impact factor: 3.714

3.  Hypertension in chronic kidney disease: role of ambulatory blood pressure monitoring.

Authors:  Rene G VanDeVoorde; Mark M Mitsnefes
Journal:  Prog Pediatr Cardiol       Date:  2015-12-17

Review 4.  Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Authors:  Amy C Wilson; Mark M Mitsnefes
Journal:  Am J Kidney Dis       Date:  2009-08       Impact factor: 8.860

Review 5.  Cardiovascular disease in children with CKD or ESRD.

Authors:  Marc R Lilien; Jaap W Groothoff
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

Review 6.  Oxidative stress in chronic kidney disease.

Authors:  Kristien Daenen; Asmin Andries; Djalila Mekahli; Ann Van Schepdael; François Jouret; Bert Bammens
Journal:  Pediatr Nephrol       Date:  2018-08-13       Impact factor: 3.714

7.  Peripheral vascular dysfunction in chronic kidney disease.

Authors:  Christopher R Martens; David G Edwards
Journal:  Cardiol Res Pract       Date:  2011-05-24       Impact factor: 1.866

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.